Business Standard

Monday, December 23, 2024 | 11:42 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19: T-cells to rescue as Omicron can't escape it, show studies

T cells, the body's weapon against virus-infected cells, were primed enough by vaccination that they defended against omicron

China, Pandemic, Omicron, Lockdown, Covid
Premium

(Left, above) Police parade suspected Covid rule-breakers through streets. Officials deliver groceries for Xi’an’s 13-million residents under lockdown (Photo: Weibo, AP/PTI)

BloombergReuters
An unsung arm of the immune system appears to protect against severe disease with the Omicron variant even when antibodies wane, helping to explain why a record wave of infections hasn’t engulfed hospitals so far.

T cells, the body’s weapon against virus-infected cells, were primed enough by vaccination that they defended against omicron in separate studies from Erasmus University in the Netherlands and the University of Cape Town in South Africa. 

The study from the University of Cape Town’s Institute of Infectious Disease and Molecular Medicine looked at patients who had recovered from Covid or been vaccinated with shots from Pfizer Inc.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in